Deficiency of the contact phase of intrinsic coagulation in a horse.

The research paper discusses the case of a 16-year-old male horse that displayed signs of weight loss, lack of appetite and recurring bouts of fever over a two-month period. The horse was discovered to suffer from a deficiency or an inhibition of the coagulation factors XI, XII or high molecular weight kininogen, a condition that while not necessarily leading to excessive bleeding, could prolong the horse’s activated partial thromboplastin time.

Medical Condition and Preliminary Findings

The focal subject of the study was a 16-year-old gelding (neutered male horse) experiencing weight loss, lack of appetite (inappetence), and recurring bouts of fever for a two-month period. An initial round of laboratory tests revealed:

• Anemia – indicating a reduced number of red blood cells or hemoglobin in the blood.
• Hypoproteinemia – a deficiency of proteins in the bloodstream.
• Thrombocytopenia – a condition describing low levels of platelets in the blood, which are essential for blood clotting.
• Extended activated partial thromboplastin time – a test result indicating a longer-than-normal time for blood clotting.

Diagnosis

Following the preliminary tests, the horse was diagnosed with a deficiency or inhibition of coagulation factors XI, XII, or high molecular weight kininogen. These factors are proteins in the blood that are critical in the process of blood coagulation (clotting).

• Factor XI and XII are part of the intrinsic pathway of coagulation and are necessary for the formation of a clot.
• High molecular weight kininogen is a circulating plasma protein that contributes to blood clotting, inflammation, and blood pressure regulation.

Implications of the Diagnosis

Under normal circumstances, a deficiency in these coagulation factors can result in a bleeding disorder. However, interestingly, this was not the case with this particular horse, as the defect was not associated with a bleeding diathesis (an unusual predisposition to bleeding).

One noticeable effect of the defect, however, was a prolongation of the horse’s activated partial thromboplastin time. This is a test that measures the time taken for a clot to form in the blood, indicating that the horse experienced delayed blood clotting. Consequently, it is recommended that this factor should be taken into account as a possible cause when there’s an incidence of extended activated partial thromboplastin time in horses.